Quick Answer
NUTRA PHARMA CORP reported Gross Profit of $247.3 thousand for fiscal year 2024.
NUTRA PHARMA CORP Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $247.3K | -37.6% |
| 2023 | $396.5K | +59.2% |
| 2022 | $249.0K | +2841.1% |
| 2021 | $8.5K | -43.2% |
| 2020 | $14.9K | -57.0% |
| 2019 | $34.7K | +146.9% |
| 2018 | $14.1K | -85.1% |
| 2017 | $94.1K | +272.1% |
| 2016 | -$54.6K | -124.2% |
| 2015 | $225.5K | -53.0% |
| 2014 | $480.2K | +654.2% |
| 2013 | $63.7K | +14.4% |
| 2012 | $55.6K | +107.7% |
| 2011 | -$720.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $75.6K | +37.9% | +7.0% |
| September 30, 2024 | $70.7K | -38.5% | +28.9% |
| June 30, 2024 | $54.8K | -35.2% | +55.8% |
| March 31, 2024 | $35.2K | -65.9% | -69.4% |
| September 30, 2023 | $115.0K | +68.7% | +35.9% |
| June 30, 2023 | $84.6K | +186.1% | -17.9% |
| March 31, 2023 | $103.1K | +1223.1% | +51.3% |
| September 30, 2022 | $68.2K | +608.3% | +130.4% |
- NUTRA PHARMA CORP showed a decrease of -37.6% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2024 period, NUTRA PHARMA CORP’s gross profit has grown by 134.4% (from -$720.0 thousand to $247.3 thousand).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: